Meeting
2021 ASCO Annual Meeting
Retrospective analysis of a novel molecular genetic risk score, “MRplus”, in BCR-ABL1 negative pediatric B-ALL: A single-center experience.
Authors
Sanjeev Kumar Gupta
Dr BRAIRCH, All India Institute of Medical Sciences, New Delhi, New Delhi, India
Sanjeev Kumar Gupta , Sameer Bakhshi , Ritu Gupta , Preity Sharma , Deepam Pushpam , Ranjit Kumar Sahoo , Atul Sharma
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Track
Hematologic Malignancies
Sub Track
Acute Leukemia
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 7029)
DOI
10.1200/JCO.2021.39.15_suppl.7029
Abstract #
7029
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
First Author: Bryan Kincheon Li
Poster
2023 ASCO Annual Meeting
Genetic study of type 2 diabetes risk in diverse populations of survivors of childhood cancer: A report from the St. Jude Lifetime Cohort (SJLIFE) and the Childhood Cancer Survivor Study (CCSS).
First Author: Cindy Im
Poster
2023 ASCO Annual Meeting
Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors.
First Author: Edward Christopher Dee
Poster
2023 ASCO Annual Meeting
Revisiting the optimal neoadjuvant immunotherapy regimen in resectable stage III melanoma based on the interferon gamma signature: A pooled analysis.
First Author: Minke W. Lucas